-
EdU Imaging Kits (Cy5) for S-Phase Assays
2026-08-24
Measure DNA synthesis with a morphology-preserving click-chemistry workflow designed for fluorescence microscopy and flow cytometry. EdU Imaging Kits (Cy5) offer a practical alternative to BrdU assays when researchers need sensitive proliferation data alongside intact antigen-binding sites.
-
N3-kethoxal: From Probe to Readout Design
2026-08-24
N3-kethoxal converts exposed guanine bases into covalently tagged molecular coordinates for RNA structure probing and accessible-DNA analysis. This guide explains how its chemistry informs assay selection, KAS-ATAC interpretation, controls, and translational workflow design.
-
Adefovir (GS-0393) for HBV Research
2026-08-23
Adefovir (GS-0393) combines a defined HBV DNA polymerase mechanism with a practical OAT1 transporter-probe application. This guide translates those properties into reproducible antiviral, uptake, and translational safety workflows while addressing formulation and interpretation risks.
-
BMS 309403: Practical FABP4 Inhibitor Workflows
2026-08-22
Use BMS 309403 to dissect how FABP4 connects fatty-acid handling with macrophage inflammation, foam-cell formation, and metabolic dysfunction. This guide combines pathway-focused assay design, dose and time optimization, translational comparisons, and troubleshooting for atherosclerosis and type 2 diabetes research.
-
Fluconazole as a Resistance-Aware Research Tool
2026-08-21
Fluconazole is more than a conventional azole control: it is a mechanistically defined perturbation for linking ergosterol disruption to fungal phenotypes. This article presents a resistance-aware framework for susceptibility assays, Candida models, formulation, and interpretation using evidence from a clinically relevant Candida auris study.
-
Angiotensin (1-7): Assay Design & New RAS Insight
2026-08-20
Explore how Angiotensin (1-7) connects Mas-receptor biology with emerging peptide–viral receptor binding data. This evidence-focused guide translates sequence, pathway, handling, and assay considerations into better experimental decisions.
-
MG-262 Proteasome Inhibition Workflows
2026-08-20
MG-262 enables reversible, cell-permeable disruption of proteasome chymotryptic activity for proteostasis, apoptosis, cell-cycle, and osteoclast studies. This workflow-focused guide connects proteasome perturbation with the reference study’s skeletal-muscle chaperone-mediated autophagy findings while emphasizing controls, washout experiments, and troubleshooting.
-
Acifran Workflows for HCAR Signaling Research
2026-08-19
Acifran enables controlled interrogation of HM74A/GPR109A and GPR109B signaling across receptor, cAMP, and lipid-metabolism workflows. This practical guide translates recent cryo-EM findings into assay design, dosing, controls, and troubleshooting choices for reproducible metabolic disorder research.
-
Paroxetine Mesylate: From SSRI to Translational Tool
2026-08-19
Paroxetine Mesylate is more than a Selective serotonin reuptake inhibitor. Its SERT activity, cytochrome P450 inhibition, and kinase-related pharmacology create a valuable platform for studying colorectal cancer biology, exposure–response relationships, and cross-domain translational questions.
-
Sulfisomidine: Enzyme and Microbial Workflows
2026-08-18
Sulfisomidine, also known as sulfamethin, connects bacterial folate-pathway studies with hPON1 inhibition and environmental transformation research. This practical guide covers assay setup, matrix-aware degradation experiments, protocol parameters, and troubleshooting strategies for reliable results.
-
Recombinant Human EGF in Mechanistic Screens
2026-08-18
Epidermal Growth Factor and recombinant human EGF can do more than stimulate growth: they can define the signaling context of mechanistic cancer assays. This guide connects APExBIO P1008 specifications with the EphA2–MYC synthetic-lethality study while emphasizing controls, interpretation, and translational limits.
-
Cyclosporin A Workflows for Mitophagy Research
2026-08-17
Cyclosporin A connects cyclophilin inhibition with practical studies of mitophagy, pyroptosis, immune signaling, and mitochondrial injury. This guide translates a recent chondrocyte study into controlled assays, handling decisions, and troubleshooting strategies without treating one pharmacologic tool as a universal mechanism proof.
-
Otilonium Bromide for Reproducible Cell Assays
2026-08-17
This scenario-based guide explains how Otilonium Bromide, SKU B1607, can be integrated into cell viability, proliferation, and cholinergic-signaling experiments without confusing receptor modulation with direct cytotoxicity. It covers formulation choice, vehicle controls, protocol parameters, interpretation, and practical vendor-selection criteria.
-
ZCL278 and the Next Wave of Cdc42 Translation
2026-08-16
ZCL278 is a selective Cdc42 inhibitor that connects molecular perturbation with measurable changes in cell motility, neuronal dynamics, and disease-relevant signaling. This thought-leadership guide places ZCL278 alongside emerging evidence that Cdc42 regulates a PKCζ/GSK-3β/β-catenin axis in kidney fibrosis, while defining the controls and model boundaries needed for credible translation.
-
(S)-(+)-Ibuprofen: COX-to-Ecosystem Insight
2026-08-15
Explore how (S)-(+)-Ibuprofen functions as a COX inhibitor across cellular, translational, and aquatic research. This evidence-based guide connects stereochemistry, prostaglandin suppression, assay design, and environmental interpretation.